Droperidol inj 2.5 mg per ml, 1 ml ampoule: Supply issue

Supply issue Active

A significant increase in demand has led to a supply issue affecting droperidol injections (pharmacode 2527138).

9 March 2023

There's a delay on the distribution of the s29 alternative. Orders can still be placed with Multichem.

Affected product

Multichem has advised Pharmac that due to a significant increase in demand they are out of stock of their funded brand of droperidol inj 2.5 mg per ml, 1 ml ampoule (Droperidol Panparma, Pharmacode 2527138).

Please note this is a hospital-only medicine.

HML listing for droperidol(external link) 

Alternative product

Multichem have secured an alternative brand of droperidol inj in order to maintain supply to hospitals. Multichem have confirmed that this product is chemically identical to their funded brand, with some slight differences in packaging artwork. This product is available under Section 29 with wastage rules applied. Details as follows: 

  • Chemical: Droperidol
  • Presentation: Inj 2.5 mcg per ml, 1 ml ampoule
  • Brand: Droperidol SXP
  • Pack size: 10
  • Subsidy and price: $43.85
  • Pharmacode: 2654326

Multichem is awaiting a licensing amendment to distribute Section 29 medicines. The alternative is available to order from Multichem and will be dispatched as soon as possible.

Resupply expected mid-April 2023

Multichem is working to expedite the next shipment of their funded product which is currently expected to arrive in NZ by mid-April 2023.

There is enough of the alternative brand secured to meet market need should the increased demand continue.

Who to contact

Contact Multichem with any queries: sales@multichem.co.nz